Abstract
Purpose: The definition of Paeoniae Radix is so unclear that there are differences in the original plants and processing methods between Japan and China. This study clarified the history of the Faculty of Pharmacy of Meijo University's contributions to the quality assurance of crude drugs as an academic institution, by organizing specimens of Paeoniae Radix-related crude drugs in the Specimen Room of the Faculty of Pharmacy of Meijo University.
Method: This study organized specimens of Paeoniae Radix-related crude drugs in the Specimen Room of the Faculty of Pharmacy of Meijo University and compared them with the historical changes of the Japanese
Pharmacopoeia standards.
Result: The Specimen Room of the Faculty of Pharmacy of Meijo University had a collection of Paeoniae Radix-related crude drug specimens of various cultivars, processing, and production area. Specimens of various cultivars and processed products grown at Meijo University were collected. Many marketed products with different lot numbers were collected before and after the change in the description of origin of
the Paeoniae Radix in the 14th revision of the Japanese Pharmacopoeia and the addition of provisions for peoniflorin content in the 12th revision.
Conclusion: The specimens of Paeoniae Radix-related crude drugs in the Specimen Room suggested that the Faculty of Pharmacy of Meijo University could have contributed to the quality assurance of crude drugs by conducting research and education in terms of cultivation of medicinal plants, production of crude drugs, and regulation of marketed products.
